Treatment of Binge Eating in Obese Patients in Primary Care

Conditions

Binge Eating | Obesity

Trial Phase

Phase 4

Trial Purpose and Description

Trial Purpose

This study will test the effectiveness of two empirically-supported but distinct treatments for recurrent binge eating in obese patients: 1) Cognitive Behavior Therapy, using a pure self-help approach and 2) sibutramine, an anti-obesity medication also found to have efficacy for binge eating. Self-help Cognitive Behavior Therapy and sibutramine will be administered alone and in combination in a primary care setting.



Participation Guidelines

Age:
18 Years - 60 Years
Gender:
Both

Eligibility Criteria


Inclusion Criteria:

- Obese (BMI >= 30)

Exclusion Criteria:

- Medication regimen that represents medical contraindication to sibutramine

- Serious unstable or uncontrolled medical conditions that represent contraindication
to sibutramine

- Pregnancy
Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
 
National Institutes of Health (NIH)
 
Yale University
Dates:
September 2007
Last Updated:
January 26, 2012
Study HIC#:
0501027352

Clinicaltrials.gov ID: NCT00537810